ArticleInternational journal of emergency medicine2025
Piperacillin-tazobactam caused post-trauma patient's postoperative leukopenia, hypokalemia, and periodic fever: a case report.
Article in International journal of emergency medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundPiperacillin-tazobactam (PT), a broad-spectrum β-lactam/β-lactamase inhibitor combination, is clinically used to treat infections caused by Gram-positive and Gram-negative aerobic and anaerobic bacteria. While gastrointestinal adverse effects, skin reactions, and fever have been previously reported during PT therapy, its association with periodic fever, leukopenia, and hypokalemia specifically in post-trauma surgical patients has not been documented. CASE PRESENTATION: We report the case of a 55-year-old male trauma patient who received PT for 17 days pre-operatively for suspected infection. He then underwent surgical procedures including rib fracture open reduction and internal fixation, along with thoracic closed drainage. Post-operatively, on day 2, the patient developed periodic fever, occurring specifically between 20:00 and 23:00 hours each night, with normal daytime temperatures. Concurrently, during PT administration, the patient exhibited leukopenia and hypokalemia. Notably, cessation of PT led to an immediate resolution of the periodic fever, gradual normalization of leukocyte counts, and restoration of potassium levels. Although PT can cause fever, diagnosis can be challenging in the post-operative setting due to the potential for confounding factors.
conclusionsThis case suggests that in surgical patients presenting with periodic fever, particularly when accompanied by leukopenia and hypokalemia after exposure to PT, the drug should be considered a potential causative agent, even if other post-operative complications are being investigated.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.